Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99
- PMID: 12598139
- DOI: 10.1016/s0140-6736(03)12513-5
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99
Abstract
Background: Transplantation of allogeneic haemopoietic stem cells can cure several primary immunodeficiencies. This European report focuses on the long-term results of such procedures done between 1968 and December, 1999, for primary immunodeficiencies.
Methods: The report includes data from 37 centres in 18 countries, which participated in a European registry for stem-cell transplantation in severe combined immuno deficiencies (SCID) and in other immunodeficiency disorders (non-SCID). 1082 transplants in 919 patients were studied (566 in 475 SCID patients, 512 in 444 non-SCID patients; four procedures excluded owing to insufficient data). Minimum follow-up of 6 months was required.
Findings: In SCID, 3-year survival with sustained engraftment was significantly better after HLA-identical than after mismatched transplantation (77% vs 54%; p=0.002) and survival improved over time. In HLA-mismatched stem-cell transplantation, B(-) SCID had poorer prognosis than B(+) SCID. However, improvement with time occurred in both SCID phenotypes. In non-SCID, 3-year survival after genotypically HLA-matched, phenotypically HLA-matched, HLA-mismatched related, and unrelated-donor transplantation was 71%, 42%, 42%, and 59%, respectively (p=0.0006). Acute graft versus host disease predicted poor prognosis whatever the donor origin except in related HLA-identical transplantation in SCID.
Interpretation: The improvement in survival over time indicates more effective prevention and treatment of disease-related and procedure-related complications--eg, infections and graft versus host disease. An important factor is better prevention of graft versus host disease in the HLA-non-identical setting by use of more efficient methods of T-cell depletion. For non-SCID, stem-cell transplantation can provide a cure, and grafts from unrelated donors are almost as beneficial as those from genetically HLA-identical relatives.
Comment in
-
Treatment options for genetically determined immunodeficiency.Lancet. 2003 Feb 15;361(9357):541-2. doi: 10.1016/S0140-6736(03)12562-7. Lancet. 2003. PMID: 12598135 No abstract available.
Similar articles
-
Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?J Allergy Clin Immunol. 2010 Sep;126(3):602-10.e1-11. doi: 10.1016/j.jaci.2010.06.015. Epub 2010 Jul 31. J Allergy Clin Immunol. 2010. PMID: 20673987
-
Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.J Pediatr. 1999 Jun;134(6):740-8. doi: 10.1016/s0022-3476(99)70291-x. J Pediatr. 1999. PMID: 10356144 Clinical Trial.
-
Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.Pediatrics. 1996 Sep;98(3 Pt 1):420-8. Pediatrics. 1996. PMID: 8784367
-
Survival After Hematopoietic Stem Cell Transplantation in Severe Combined Immunodeficiency (SCID): A Worldwide Review of the Prognostic Variables.Clin Rev Allergy Immunol. 2024 Apr;66(2):192-209. doi: 10.1007/s12016-024-08993-5. Epub 2024 Apr 30. Clin Rev Allergy Immunol. 2024. PMID: 38689103 Review.
-
Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.Immunol Res. 2011 Apr;49(1-3):25-43. doi: 10.1007/s12026-010-8191-9. Immunol Res. 2011. PMID: 21116871 Free PMC article. Review.
Cited by
-
Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency.Curr Pediatr Rep. 2015 Mar 1;3(1):1-10. doi: 10.1007/s40124-014-0071-7. Curr Pediatr Rep. 2015. PMID: 25821657 Free PMC article.
-
Effects of conditioning regimens and T cell depletion in hematopoietic cell transplantation for primary immune deficiency.Biol Blood Marrow Transplant. 2012 Dec;18(12):1911-20. doi: 10.1016/j.bbmt.2012.07.014. Epub 2012 Jul 27. Biol Blood Marrow Transplant. 2012. PMID: 22842333 Free PMC article.
-
Treosulfan-based conditioning for inborn errors of immunity.Ther Adv Hematol. 2021 May 20;12:20406207211013985. doi: 10.1177/20406207211013985. eCollection 2021. Ther Adv Hematol. 2021. PMID: 34094045 Free PMC article. Review.
-
Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies.Front Immunol. 2015 May 21;6:250. doi: 10.3389/fimmu.2015.00250. eCollection 2015. Front Immunol. 2015. PMID: 26052330 Free PMC article. Review.
-
Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders.J Adv Res. 2015 May;6(3):449-58. doi: 10.1016/j.jare.2014.11.001. Epub 2014 Nov 7. J Adv Res. 2015. PMID: 26257943 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials